From April 1, 2022 to June 30, 2022, the company has repurchased 744,858 shares, representing 2.9% for $2.89 million. With this, the company has completed the repurchase of 2,675,872 shares, representing 10.03% for $11.44 million under the buyback announced on November 17, 2021.
La Jolla Pharmaceutical Company
Equities
LJPC
US5034596040
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-1.90% | 103B | |
+1.79% | 95.28B | |
+2.79% | 22.15B | |
-16.16% | 21.02B | |
-8.40% | 18.15B | |
-41.01% | 16.73B | |
-14.89% | 16.05B | |
+4.38% | 13.68B | |
+34.27% | 12.17B |